Beta-endorphin decline in late luteal phase dysphoric disorder

Area of Science:

• Neuroendocrinology
• Reproductive endocrinology
• Psychiatry

Background:

• Late luteal phase dysphoric disorder, commonly known as premenstrual syndrome (PMS), is a condition affecting many women.
• The underlying neurobiological mechanisms of PMS remain incompletely understood.
• Previous hypotheses have suggested hormonal imbalances may play a role.

Purpose of the Study:

• To investigate the beta-endorphin hypothesis of premenstrual syndrome.
• To compare beta-endorphin levels in women with PMS versus controls during the luteal phase.
• To examine the relationship between beta-endorphin and other key hormones during the menstrual cycle.

Main Methods:

• A case-control study involving 22 women diagnosed with PMS and 22 age-matched healthy controls.
• Hormonal levels, including beta-endorphin, ACTH, FSH, LH, cortisol, prolactin, and TRH, were measured on two specific days post-menses.
• Statistical analysis was used to compare hormone levels between the PMS and control groups.

Main Results:

• PMS subjects showed a significantly greater decrease in beta-endorphin levels compared to controls (p < .001).
• No significant differences or relationships were observed for ACTH, FSH, LH, cortisol, prolactin, or TRH between the groups.
• The findings support a role for beta-endorphin fluctuations in the pathophysiology of PMS.

Conclusions:

• The study suggests that a significant decline in beta-endorphin may be a key factor in the development of PMS symptoms.
• The observed beta-endorphin drop might trigger a noradrenergic rebound, contributing to dysphoria.
• Models of opioid withdrawal and bipolar disorder are proposed for understanding PMS pathophysiology.